Oxygen is one of the three basic essentials for sustaining life. Today's medical technology can supply oxygen to patients with lung damage from pneumonia, sepsis, and other bacterial or viral infections, physical trauma, and chemical or smoke inhalation through mechanical ventilation (MV) or extracorporeal membrane oxygenation (ECMO). Despite these treatments, the mortality rate of patients ranges from 31–74% . MV has been an ineffective method for delivering oxygen to the body in these cases because oxygen exchange is decreased by damage to the lung and because of increased stress caused to the injured lung by the treatment. ECMO is an expensive alternative therapy with limited availability in hospitals and length of treatment. ECMO is able to bypass the injured lungs to deliver oxygen and allow the lungs to heal, however, there is a high risk of thrombosis and contamination of the blood because...
Peritoneal Microbubble Oxygenation: An Extrapulmonary Respiration Treatment in Rabbits1
Manuscript received February 21, 2014; final manuscript received March 3, 2014; published online July 21, 2014. Editor: Arthur G. Erdman.
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
- Search Site
Legband, N., Feshitan, J., Borden, M., and Terry, B. (July 21, 2014). "Peritoneal Microbubble Oxygenation: An Extrapulmonary Respiration Treatment in Rabbits." ASME. J. Med. Devices. September 2014; 8(3): 030944. https://doi.org/10.1115/1.4027112
Download citation file:
- Ris (Zotero)
- Reference Manager